Neuroinflammatory Response to TNFα and IL1β Cytokines Is Accompanied by an Increase in Glycolysis in Human Astrocytes In Vitro.
Astrocytes
/ drug effects
Brain
/ drug effects
Cell Line
Energy Metabolism
/ drug effects
Gliosis
/ drug therapy
Glycolysis
/ drug effects
Humans
Inflammation
/ genetics
Interleukin-1beta
/ genetics
Neurogenesis
/ drug effects
STAT3 Transcription Factor
/ genetics
Signal Transduction
/ drug effects
Tumor Necrosis Factor-alpha
/ genetics
astrocytes
astrogliosis
energy metabolism
neuroenergetic
neuroinflammation
reactive astrocytes
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
14 Apr 2021
14 Apr 2021
Historique:
received:
17
03
2021
revised:
02
04
2021
accepted:
06
04
2021
entrez:
30
4
2021
pubmed:
1
5
2021
medline:
13
5
2021
Statut:
epublish
Résumé
Astrogliosis has been abundantly studied in rodents but relatively poorly in human cells due to limited access to the brain. Astrocytes play important roles in cerebral energy metabolism, and are also key players in neuroinflammation. Astroglial metabolic and inflammatory changes as a function of age have been reported, leading to the hypothesis that mitochondrial metabolism and inflammatory responses are interconnected in supporting a functional switch of astrocytes from neurotrophic to neurotoxic. This study aimed to explore the metabolic changes occurring in astrocytes during their activation. Astrocytes were derived from human ReN cell neural progenitors and characterized. They were activated by exposure to tumor necrosis factor alpha (TNFα) or interleukin 1β (IL1β) for 24 h. Astrocyte reaction and associated energy metabolic changes were assessed by immunostaining, gene expression, proteomics, metabolomics and extracellular flux analyses. ReN-derived astrocytes reactivity was observed by the modifications of genes and proteins linked to inflammation (cytokines, nuclear factor-kappa B (NFκB), signal transducers and activators of transcription (STATs)) and immune pathways (major histocompatibility complex (MHC) class I). Increased NFκB1, NFκB2 and STAT1 expression, together with decreased STAT3 expression, suggest an activation towards the detrimental pathway. Strong modifications of astrocyte cytoskeleton were observed, including a glial fibrillary acidic protein (GFAP) decrease. Astrogliosis was accompanied by changes in energy metabolism characterized by increased glycolysis and lactate release. Increased glycolysis is reported for the first time during human astrocyte activation. Astrocyte activation is strongly tied to energy metabolism, and a possible association between NFκB signaling and/or MHC class I pathway and glycolysis is suggested.
Identifiants
pubmed: 33920048
pii: ijms22084065
doi: 10.3390/ijms22084065
pmc: PMC8071021
pii:
doi:
Substances chimiques
IL1B protein, human
0
Interleukin-1beta
0
STAT3 Transcription Factor
0
STAT3 protein, human
0
Tumor Necrosis Factor-alpha
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Swiss Centre for Applied Human Toxicology
ID : CP3
Références
Anal Chim Acta. 2020 Apr 8;1105:28-44
pubmed: 32138924
Nat Rev Neurosci. 2018 Apr;19(4):235-249
pubmed: 29515192
Front Cell Dev Biol. 2019 Aug 07;7:154
pubmed: 31448275
Brain Res. 2017 Jan 1;1654(Pt A):1-8
pubmed: 27769789
Front Neurosci. 2017 Feb 02;11:43
pubmed: 28210209
Ann Neurol. 2012 Nov;72(5):750-65
pubmed: 22941903
Neuron. 2015 May 20;86(4):883-901
pubmed: 25996133
Brain Struct Funct. 2017 Jul;222(5):2017-2029
pubmed: 28280934
Acta Neuropathol. 2010 Jan;119(1):7-35
pubmed: 20012068
Glia. 2000 May;30(3):253-70
pubmed: 10756075
Int Immunopharmacol. 2016 Aug;37:31-42
pubmed: 26778152
Cancers (Basel). 2019 Aug 26;11(9):
pubmed: 31454998
Brain Res. 2016 Oct 1;1648(Pt A):90-100
pubmed: 27402431
J Neuroinflammation. 2014 Jan 21;11:10
pubmed: 24444311
Glia. 2018 May;66(5):1034-1052
pubmed: 29380419
Metabolomics. 2015;11(4):822-837
pubmed: 26109926
J Neurosci. 2013 Jul 31;33(31):12870-86
pubmed: 23904622
J Neurochem. 2009 Jul;110(2):765-78
pubmed: 19522780
J Cereb Blood Flow Metab. 2009 Nov;29(11):1780-9
pubmed: 19675565
Neurosci Lett. 2014 Apr 17;565:30-8
pubmed: 24406153
Neurotoxicology. 2020 Jan;76:191-199
pubmed: 31738978
Acta Neuropathol. 2013 Sep 29;126(5):711-724
pubmed: 24077734
Prog Neurobiol. 2000 Dec;62(6):649-71
pubmed: 10880854
Trends Immunol. 2007 Mar;28(3):138-45
pubmed: 17276138
Annu Rev Cell Dev Biol. 2011;27:441-64
pubmed: 21985671
Nature. 2017 Jan 26;541(7638):481-487
pubmed: 28099414
J Cereb Blood Flow Metab. 2007 Nov;27(11):1766-91
pubmed: 17579656
J Chromatogr A. 2019 May 10;1592:47-54
pubmed: 30685186
J Physiol. 2018 Feb 1;596(3):347-350
pubmed: 29292516
J Neurosci. 2004 Jul 7;24(27):6202-8
pubmed: 15240812
Nat Rev Neurosci. 2005 Aug;6(8):626-40
pubmed: 16025096
J Neurochem. 2006 Aug;98(3):641-53
pubmed: 16787421
Front Cell Neurosci. 2013 Oct 11;7:179
pubmed: 24130515
Acta Histochem. 2016 Jun;118(5):544-52
pubmed: 27246286
Glia. 2014 Jul;62(7):1125-41
pubmed: 24692237
Brain. 2010 Aug;133(Pt 8):2248-63
pubmed: 20826430
Glia. 2008 Jul;56(9):975-89
pubmed: 18383346
J Cereb Blood Flow Metab. 2012 Jul;32(7):1152-66
pubmed: 22027938
Immunity. 2013 Apr 18;38(4):633-43
pubmed: 23601682
Neurosci Lett. 2017 Apr 24;647:97-103
pubmed: 28341478
J Clin Invest. 2012 Jul;122(7):2454-68
pubmed: 22653056
J Exp Med. 2005 Jul 4;202(1):145-56
pubmed: 15998793
Nat Med. 2006 Jul;12(7):829-34
pubmed: 16783372
Braz J Med Biol Res. 1999 May;32(5):619-31
pubmed: 10412574
Neuron. 2003 Jan 23;37(2):275-86
pubmed: 12546822
Metab Brain Dis. 2015 Feb;30(1):25-30
pubmed: 25034458
Front Physiol. 2015 Jan 14;5:522
pubmed: 25642192
Methods Mol Biol. 2011;681:459-72
pubmed: 20978983
Nat Rev Neurosci. 2015 May;16(5):249-63
pubmed: 25891508
Neuroscience. 2005;134(3):771-82
pubmed: 15994020
J Neurochem. 2011 Feb;116(4):564-76
pubmed: 21143598
Trends Neurosci. 2009 Dec;32(12):638-47
pubmed: 19782411
Methods Mol Biol. 2017;1613:101-124
pubmed: 28849560
Trends Immunol. 2016 Sep;37(9):608-620
pubmed: 27443914
J Neural Transm (Vienna). 2006 Nov;113(11):1709-15
pubmed: 16736247
J Exp Biol. 2006 Jun;209(Pt 12):2304-11
pubmed: 16731806
Proc Natl Acad Sci U S A. 1994 Oct 25;91(22):10625-9
pubmed: 7938003
Sci Data. 2019 Feb 19;6:190016
pubmed: 30778261
J Neurol Sci. 1992 Aug;111(1):65-72
pubmed: 1402999
Cell. 2013 Jun 6;153(6):1239-51
pubmed: 23746840
Mol Med Rep. 2018 Nov;18(5):4516-4522
pubmed: 30221665
Prog Neurobiol. 2020 Jan;184:101719
pubmed: 31704314
Glia. 2020 Nov;68(11):2246-2263
pubmed: 32277522
PLoS One. 2014 Jul 15;9(7):e102003
pubmed: 25025494
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Cold Spring Harb Perspect Biol. 2014 Nov 07;7(2):a020420
pubmed: 25380660
Cell Metab. 2017 Aug 1;26(2):361-374.e4
pubmed: 28768175
Nature. 2012 Jul 26;487(7408):443-8
pubmed: 22801498
J Biol Chem. 2015 Jan 2;290(1):46-55
pubmed: 25406319
Glia. 2019 Dec;67(12):2221-2247
pubmed: 31429127
Cell Metab. 2016 Jan 12;23(1):94-102
pubmed: 26698914
Aging Cell. 2014 Dec;13(6):1059-67
pubmed: 25233945
Philos Trans R Soc Lond B Biol Sci. 1999 Jul 29;354(1387):1155-63
pubmed: 10466143
J Neurosci. 2013 Jun 26;33(26):10924-33
pubmed: 23804112
Science. 1956 Feb 24;123(3191):309-14
pubmed: 13298683